Craig Taylor work email
- Valid
- Valid
Craig Taylor personal email
Internationally experienced life science commercial/operations professional with broad multidisciplinary experience spanning therapeutics, diagnostics, medical devices, and genomics. Significant functional experience in operations, finance, business development, and market access, spanning Fortune 250 companies to early stage start-ups. Raised a total of $75 million in venture capital funding across two start-ups as part of the leadership team (with one successful exit through an acquisition by Takeda Pharmaceutical Company).
-
Sr Director, Business Operations And DevelopmentNouscom
-
Sr Director, Business Operations & DevelopmentNouscom Sep 2024 - PresentBs, Basel-City, ChNouscom is a clinical-stage immuno-oncology company developing next generation, off-the-shelf and personalized cancer immunotherapies. Nouscom’s proprietary viral vector platform has the capacity to encode large payloads of neoantigens, or other immunomodulators, and has clinically demonstrated the ability to safely and potently harness the power of the immune system.
-
Sr Director, Strategic OperationsTenpoint Therapeutics Ltd Jun 2023 - Sep 2024London, GbTenpoint is a biotechnology company pursuing vision-restoring, cell-based therapeutics and in vivo reprogramming to address degenerative ocular diseases. To date, we have raised $70 million in VC funding. -
Director, Takeda Adt OperationsTakeda Apr 2022 - Jun 2023Tokyo, JpUpon the successful acquisition of Adaptate Biotherapeutics by Takeda in April 2022, I carried on in my previous role and joined the Takeda team. -
Head Of Business OperationsAdaptate Sep 2019 - Apr 2022London, GbAdaptate Biotherapeutics is an immunotherapy company developing therapeutic antibodies to modulate the activity of gamma delta T cells. Our exquisitely targeted approach enables us to harness and amplify the potential of patients’ own immune cells in situ, effectively addressing the challenges encountered by other immunotherapeutic approaches in treating solid tumors.The company was a spin-out from GammaDelta Therapeutics in late 2019, receiving investment from both Abingworth and Takeda Pharmaceutical Company.Adaptate was acquired by Takeda in April 2022. -
Director Of Business Development At Virion BiotherapeuticsVirion Biotherapeutics Jun 2019 - Sep 2019London-based biotech that is transforming the prophylaxis and treatment of respiratory viral infections by developing a first-in-class, pan-viral RNA-based therapy -
Vp (Head) Of Business DevelopmentCongenica Feb 2015 - May 2019Cambridge, Cambridgeshire, GbCongenica is a UK company founded on pioneering research from the Wellcome Trust Sanger Institute, NHS clinicians and regional genetic testing laboratories. We’ve translated this research into the gold standard clinical genomic analytics platform, Sapientia®, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide actionable interpretation of genetic disease for patients.As one of the first employees, I worked with the CEO from 2012 onward to craft the business plan and get the company off the ground. I've been heavily involved with fundraising, partnering, and guiding corporate strategy. -
ConsultantGfk Market Access Sep 2013 - Jan 2015Nuremberg, Bavaria, De• Delivered strategic initiatives for pharmaceutical, biotechnology, and diagnostic clients in the areas of market strategy, opportunity analysis, pricing & reimbursement, health economics and market access.• Analysed vast amounts of data from primary and secondary research programs, uncovering the key takeaways and delivering insightful, evidence-based recommendations to clients.• Executed comprehensive interview programmes and advisory boards with high level KOLs, physicians and policy makers, distilling the key insights into actionable drug development strategies at the national and regional levels. -
Business Strategy ConsultantIndependent Consultant Sep 2012 - May 2013Company 1:• Provided a comprehensive opportunity analysis of non-invasive prenatal tests (NIPTs) to a newly formed genomic analysis companyCompany 2:• Investigated both the research and clinical applications for a novel cell separation technology, providing strategic direction with the intent of spinning out a company (Birmingham, UK).• Contributed as the commercial leader by evaluating the market size, competition, customers, patent strength, and regulatory landscape, as well as exploring potential funding opportunities.
-
Business Development InternF-Star Biotechnology Ltd. Jul 2012 - Sep 2012Cambridge, Cambridgeshire, Gb• Identified potential pharma partners, evaluating their past acquisition/in-licensing targets, current M&A appetite, and drug pipeline, ultimately arriving at two target companies to pursue• Assessed the attractiveness of Korean biotech market, identifying new business opportunities• Investigated the firm’s IP position in relation to in-licensing technology from an external entity• Delivered a robust competitor analysis, allowing for a more potent market positioning strategy -
Supply Chain ManagerNanostring Technologies Sep 2009 - Jul 2011Seattle, Wa, Us• Led negotiations of multi-year, international business agreements with key partners from Japan, Norway, Germany and The Netherlands, totaling US$13m in projected purchases (equal to 72% of revenue at the time)• Provided operational guidance on cross functional product development teams (with responsibilities for concept evaluation through to product launch) that delivered 5 new initiatives to the market, including a breast cancer diagnostic now marketed in the US and Europe as Prosigna• Through strategic procurement initiatives, generated a 9.5% margin increase on the company’s highest selling product, equating to 330% of an individual goal and 95% of the corporate goal that year• Implemented an ISO 13485 quality system throughout the supply chain, allowing the company to proceed with regulatory approval to sell clinical diagnostic products• Managed an annual procurement budget of US$8m -
Inventory Control Specialist IiNanostring Technologies May 2008 - Nov 2009Seattle, Wa, Us• Established the supply chain groundwork, enabling the launch of the first commercial product• Reduced the purchasing price of 15 high-volume items by an average of 24%• Negotiated new contracts with global logistic providers and utilized novel temperature controlled shipping containers to reduce shipping costs by 47%, passing the savings directly to customers• Helped implement an ERP system, allowing the business to run more efficiently
-
Supply Chain PlannerStarbucks Coffee Company Jun 2006 - Feb 2008Seattle, Wa, Us• Led an organisational change initiative that enabled the Operations division to optimise performance by focusing on business critical issues• Entrusted to manage the largest product portfolio within the organisation- US$82 million across 25 distribution centers• Selected as co-Project Manager of the ‘Holiday Team’, overseeing both internal and external stakeholders to ensure completion of critical tasks for the global holiday launch, which is the company’s most important initiative each year -
Supply Chain InternAmgen Jun 2005 - Sep 2005Thousand Oaks, Ca, Us• Developed a business continuity plan, enabling uninterrupted operations in a natural disaster• Created an inventory database that allowed the logistics team to fulfill orders more precisely, eliminating 80% of non value-added time
Craig Taylor Skills
Craig Taylor Education Details
-
University Of CambridgeFinance Concentration -
Western Washington UniversityManufacturing And Supply Chain Management
-
Centralia CollegeGeneral Studies With Business Emphasis
Frequently Asked Questions about Craig Taylor
What company does Craig Taylor work for?
Craig Taylor works for Nouscom
What is Craig Taylor's role at the current company?
Craig Taylor's current role is Sr Director, Business Operations and Development.
What is Craig Taylor's email address?
Craig Taylor's email address is ct****@****otx.com
What schools did Craig Taylor attend?
Craig Taylor attended University Of Cambridge, Western Washington University, Centralia College.
What are some of Craig Taylor's interests?
Craig Taylor has interest in Health.
What skills is Craig Taylor known for?
Craig Taylor has skills like Strategy, Biotechnology, Cross Functional Team Leadership, Business Development, Leadership, Life Sciences, Business Strategy, Pharmaceutical Industry, Product Development, Project Management, Competitive Analysis, Program Management.
Who are Craig Taylor's colleagues?
Craig Taylor's colleagues are Martina Sonnino, Maria Picardi, Laura Seclì, Giulia Sdruscia, Anna Maria Petrone, Giuseppina Romano, Barbara De Mieri.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial